Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Na, Kyoung Sae ^a   Won, Eunsoo ^b   Kang, June ^b   Chang, Hun Soo ^c   Yoon, Ho Kyoung ^b   Tae, Woo Suk ^d   Kim, Yong Ku ^b   Lee, Min Soo ^b   Joe, Sook Haeng ^b   Kim, Hyun ^b   Ham, Byung Joo ^b  

^a Gachon University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Soonchunhyang University   (South Korea)

^d College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; BLOOD; BRAIN CORTEX; BRAIN MAPPING; DNA METHYLATION; FEMALE; FRONTAL LOBE; GENETICS; HUMAN; MAJOR DEPRESSION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROMOTER REGION;

ADULT; BRAIN MAPPING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; DNA METHYLATION; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC;

EID: 84958281115     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21089     Document Type: Article

References (62)

1. Kramar, E. A. et al. BDNF upregulation rescues synaptic plasticity in middle-aged ovariectomized rats. Neurobiol Aging 33, 708-719, doi: 10.1016/j.neurobiolaging.2010.06.008 (2012).
2. Zou, Y. F. et al. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur Neuropsychopharmacol 20, 535-544, doi: 10.1016/j.euroneuro.2009.12.005 (2010).
3. Sen, S., Duman, R., Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: metaanalyses and implications. Biol Psychiatry 64, 527-532, doi: 10.1016/j.biopsych.2008.05.005 (2008).
4. Nestler, E. J. Epigenetic mechanisms of depression. JAMA Psychiatry 71, 454-456, doi: 10.1001/jamapsychiatry.2013.4291 (2014).
5. Vialou, V., Feng, J., Robison, A. J., Nestler, E. J. Epigenetic mechanisms of depression and antidepressant action. Annu Rev Pharmacol Toxicol 53, 59-87, doi: 10.1146/annurev-pharmtox-010611-134540 (2013).
6. Tsankova, N. M. et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9, 519-525, doi: 10.1038/nn1659 (2006).
7. Guintivano, J., Arad, M., Gould, T. D., Payne, J. L., Kaminsky, Z. A. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry 19, 560-567, doi: 10.1038/mp.2013.62 (2014).
8. Unternaehrer, E. et al. Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF ) after acute psychosocial stress. Transl Psychiatry 2, e150, doi: 10.1038/tp.2012.77 (2012).
9. D'Addario, C. et al. Epigenetic modulation of BDNF gene in patients with major depressive disorder. Biol Psychiatry 73, e6-7, doi: 10.1016/j.biopsych.2012.07.009 (2013).
10. Singh, K. K. et al. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat Neurosci 11, 649-658, doi: 10.1038/nn.2114 (2008).
11. Borrelli, E., Nestler, E. J., Allis, C. D., Sassone-Corsi, P. Decoding the epigenetic language of neuronal plasticity. Neuron 60, 961-974, doi: 10.1016/j.neuron.2008.10.012 (2008).
12. Harrison, P. J. The neuropathology of primary mood disorder. Brain 125, 1428-1449 (2002).
13. Bora, E., Fornito, A., Pantelis, C., Yucel, M. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord 138, 9-18, doi: 10.1016/j.jad.2011.03.049 (2012).
14. Mountcastle, V. B. The columnar organization of the neocortex. Brain 120 (Pt 4), 701-722 (1997).
15. Rakic, P. Specification of cerebral cortical areas. Science 241, 170-176 (1988).
16. Roth, T. L., Lubin, F. D., Funk, A. J., Sweatt, J. D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 65, 760-769, doi: 10.1016/j.biopsych.2008.11.028 (2009).
17. Kleimann, A. et al. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy. J Neural Transm (Vienna) 122, 925-928, doi: 10.1007/s00702-014-1336-6 (2015).
18. Qiu, L. et al. Regional increases of cortical thickness in untreated, first-episode major depressive disorder. Transl Psychiatry 4, e378, doi: 10.1038/tp.2014.18 (2014).
19. Han, K. M. et al. Cortical thickness, cortical and subcortical volume, and white matter integrity in patients with their first episode of major depression. J Affect Disord 155, 42-48, doi: 10.1016/j.jad.2013.10.021 (2014).
20. Liberto, C. M., Albrecht, P. J., Herx, L. M., Yong, V. W., Levison, S. W. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 89, 1092-1100, doi: 10.1111/j.1471-4159.2004.02420.x (2004).
21. Stenz, L. et al. BDNF promoter I methylation correlates between post-mortem human peripheral and brain tissues. Neurosci Res 91, 1-7, doi: 10.1016/j.neures.2014.10.003 (2015).
22. Kim, J. M. et al. A longitudinal study of BDNF promoter methylation and genotype with poststroke depression. J Affect Disord 149, 93-99, doi: 10.1016/j.jad.2013.01.008 (2013).
23. Frodl, T. et al. Effects of early-life adversity on white matter diffusivity changes in patients at risk for major depression. J Psychiatry Neurosci 37, 37-45, doi: 10.1503/jpn.110028 (2012).
24. Liao, Y. et al. Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. J Psychiatry Neurosci 38, 49-56, doi: 10.1503/jpn.110180 (2013).
25. Bibel, M., Barde, Y. A. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14, 2919-2937 (2000).
26. Chatterjee, D. et al. Maternal isolation alters the expression of neural proteins during development: 'Stroking' stimulation reverses these effects. Brain Res 1158, 11-27, doi: 10.1016/j.brainres.2007.04.069 (2007).
27. Tost, H. et al. Effects of the BDNF Val66Met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacology 38, 525-532, doi: 10.1038/npp.2012.214 (2013).
28. Snyder, H. R. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull 139, 81-132, doi: 10.1037/a0028727 (2013).
29. Nitschke, J. B., Mackiewicz, K. L. Prefrontal and anterior cingulate contributions to volition in depression. Int Rev Neurobiol 67, 73-94, doi: 10.1016/S0074-7742(05)67003-1 (2005).
30. Rogers, M. A. et al. Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res 50, 1-11, doi: 10.1016/j.neures.2004.05.003 (2004).
31. Rive, M. M. et al. Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies. Neurosci Biobehav Rev 37, 2529-2553, doi: 10.1016/j.neubiorev.2013.07.018 (2013).
32. Barreto, R. A., Walker, F. R., Dunkley, P. R., Day, T. A., Smith, D. W. Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression? BMC Neurosci 13, 125, doi: 10.1186/1471-2202-13-125 (2012).
33. Peterson, B. S. et al. Cortical thinning in persons at increased familial risk for major depression. Proc Natl Acad Sci USA 106, 6273-6278, doi: 10.1073/pnas.0805311106 (2009).
34. Jung, J. et al. Impact of lingual gyrus volume on antidepressant response and neurocognitive functions in Major Depressive Disorder: a voxel-based morphometry study. J Affect Disord 169, 179-187, doi: 10.1016/j.jad.2014.08.018 (2014).
35. Maller, J. J. et al. Occipital bending in depression. Brain 137, 1830-1837, doi: 10.1093/brain/awu072 (2014).
36. Poo, M. M. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2, 24-32, doi: 10.1038/35049004 (2001).
37. Kohara, K. et al. Inhibitory but not excitatory cortical neurons require presynaptic brain-derived neurotrophic factor for dendritic development, as revealed by chimera cell culture. J Neurosci 23, 6123-6131 (2003).
38. Bhagwagar, Z. et al. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry 61, 806-812, doi: 10.1016/j.biopsych.2006.08.048 (2007).
39. Sanacora, G. et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61, 705-713, doi: 10.1001/archpsyc.61.7.705 (2004).
40. Abdallah, C. G. et al. Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder. Psychother Psychosom 83, 298-307, doi: 10.1159/000361078 (2014).
41. Qiu, L. et al. Characterization of major depressive disorder using a multiparametric classification approach based on high resolution structural images. J Psychiatry Neurosci 39, 78-86 (2014).
42. Kronenberg, G. et al. Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression. J Psychiatr Res 43, 1112-1117, doi: 10.1016/j.jpsychires.2009.03.007 (2009).
43. Hickie, I. et al. Reduced hippocampal volumes and memory loss in patients with early-and late-onset depression. Br J Psychiatry 186, 197-202, doi: 10.1192/bjp.186.3.197 (2005).
44. Frodl, T. et al. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 31, 316-323 (2006).
45. van Eijndhoven, P. et al. Amygdala volume marks the acute state in the early course of depression. Biol Psychiatry 65, 812-818, doi: 10.1016/j.biopsych.2008.10.027 (2009).
46. Cheng, Y. Q. et al. Brain volume alteration and the correlations with the clinical characteristics in drug-naive first-episode MDD patients: a voxel-based morphometry study. Neurosci Lett 480, 30-34, doi: 10.1016/j.neulet.2010.05.075 (2010).
47. Vasic, N., Walter, H., Hose, A., Wolf, R. C. Gray matter reduction associated with psychopathology and cognitive dysfunction in unipolar depression: a voxel-based morphometry study. J Affect Disord 109, 107-116, doi: 10.1016/j.jad.2007.11.011 (2008).
48. Schmaal, L. et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry, doi: 10.1038/mp.2015.69 (2015).
49. Song, X. et al. Decreased cortical thickness in drug naive first episode schizophrenia: in relation to serum levels of BDNF. J Psychiatr Res 60, 22-28, doi: 10.1016/j.jpsychires.2014.09.009 (2015).
50. Zugman, A. et al. Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls. Psychiatry Res, doi: 10.1016/j.pscychresns.2015.08.009 (2015).
51. Legge, R. M. et al. Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder. Br J Psychiatry 206, 379-384, doi: 10.1192/bjp.bp.113.143529 (2015).
52. Murphy, M. L. et al. Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder. Biol Psychiatry 72, 663-670, doi: 10.1016/j.biopsych.2012.04.015 (2012).
53. Melas, P. A. et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol 15, 669-679, doi: 10.1017/S1461145711000940 (2012).
54. Molendijk, M. L. et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 16, 1088-1095, doi: 10.1038/mp.2010.98 (2011).
55. Carlberg, L. et al. Brain-derived neurotrophic factor (BDNF)-epigenetic regulation in unipolar and bipolar affective disorder. J Affect Disord 168, 399-406, doi: 10.1016/j.jad.2014.07.022 (2014).
56. Choi, S. et al. Association of brain-derived neurotrophic factor DNA methylation and reduced white matter integrity in the anterior corona radiata in major depression. J Affect Disord 172C, 74-80, doi: 10.1016/j.jad.2014.09.042 (2014).
57. Oldfield, R. C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9, 97-113 (1971).
58. APA. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition. fourth edn, (American Psychiatric Association (APA), 1994).
59. Hahn, O.-S. et al. Development of Korean Version of Structured Clinical Interview Schedule for DSM-IV Axis I Disorder : Interrater Reliability. Korean J Neuropsychiatr Assoc 39, 362-372 (2000).
60. Devlin, A. M., Brain, U., Austin, J., Oberlander, T. F. Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One 5, e12201, doi: 10.1371/journal.pone.0012201 (2010).
61. Fischl, B., Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97, 11050-11055, doi: 10.1073/pnas.200033797 (2000).
62. McLaughlin, K. A. et al. Widespread Reductions in Cortical Thickness Following Severe Early-Life Deprivation: A Neurodevelopmental Pathway to Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry, doi: 10.1016/j.biopsych.2013.08.016 (2013).